Incidence of Post-therapeutic Malignancies in Benign and Malignant Gastric Diseases, Human Leukocyte Antigen-restricted Human Endogenous Retrovirus Gene-derived Peptides, and Survival-Reference-Cited by-同舟云学术

Incidence of Post-therapeutic Malignancies in Benign and Malignant Gastric Diseases, Human Leukocyte Antigen-restricted Human Endogenous Retrovirus Gene-derived Peptides, and Survival

Published:2024-01-18 Issue:1 Volume:32 Page:17-30
ISSN:1344-6835
Container-title:Annals of Cancer Research and Therapy
language:en
Short-container-title:Ann. Cancer Res. Therap.

Author:

Ogoshi Kyoji¹²,Iwata Kunihiro¹,Kunisaki Chikara³,Takenoshita Seiichi⁴,Isono Kaichi⁵

Affiliation:

1. Department of Gastrointestinal Surgery, Tokai University

2. Division of Surgery, Seisho Hospital

3. Department of Surgery, Gastroenterological Center, Yokohama City University

4. Department of Surgery, Fukushima Medical University Hospital

5. Department of Surgery, Chiba University

Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Link

https://www.jstage.jst.go.jp/article/acrt/32/1/32_17/_pdf

Reference43 articles.

1. 1) Zon RT, Goss E, Vogel VG, et al. American Society of Clinical Oncology Policy Statement: The Role of the Oncologist in Cancer Prevention and Risk Assessment. JCO. 2009;27(6):986-93. doi: 10.1200/JCO.2008.16.3691

2. 2) Kar SP, Beesley J, Amin Al Olama A, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. 2016;6(9):1052-67. doi: 10.1158/2159-8290.CD-15-1227

3. 3) Weiss RA. The discovery of endogenous retroviruses. Retrovirology. 2006;3(1):67. doi: 10.1186/1742-4690-3-67

4. 4) Vargiu L, Rodriguez-Tomé P, Sperber GO, et al. Classification and characterization of human endogenous retroviruses; mosaic forms are common. Retrovirology. 2016;13(1):7. doi: 10.1186/s12977-015-0232-y

5. 5) Alcazer V, Bonaventura P, Depil S. Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers. Cancers. 2020;12(3):610. doi: 10.3390/cancers12030610